‘Skinny Fat’ Contributes to Heart Attack, Stroke Risk
TUESDAY, Oct. 21, 2025 Hidden deposits of fat deep inside the abdomen and liver can quietly increase your risk of stroke and heart attack, even if you appear to
GLP-1 Drugs Help Protect Against Sleep Apnea, Study Says
TUESDAY, Oct. 21, 2025 Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says.Type 2 d
One Of The Deadliest Syndromes You’ve Never Heard About
TUESDAY, Oct. 21, 2025 It s one of the deadliest syndromes you ve never heard of, but experts are hoping to change that.Nearly 9 of 10 Americans have not heard
One Of The Deadliest Syndromes You’ve Never Heard About
TUESDAY, Oct. 21, 2025 It s one of the deadliest syndromes you ve never heard of, but experts are hoping to change that.Nearly 9 of 10 Americans have not heard
Wilmington PharmaTech, on mission to boost US drug ingredient capacity, snares investment from PE firm Curewell
Private equity firm Curewell Capital is aiming to close the gap in U.S. API production with a majority investment in specialty CDMO Wilmington PharmaTech.
India’s ACG pumps $200M into its first US empty-capsule production facility
ACG, a supplier for solid dose drug manufacturers, is pumping $200 million into what will be the India-based company’s first empty-capsule production facility in the U.S.
Merck grows again in Va. with $3B small-molecule drug plant, part of planned $70B US outlay
The investment is part of the New Jersey company’s plan to spend more than $70 billion on manufacturing, R&D and capital projects in the U.S. starting this year.
AstraZeneca to spend $445M to boost production of Lokelma at Texas plant
With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the capabilities of AZ’s
Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis
In addition to substantial spray drying capacity, new CDMO Codis says it’s also equipped to handle commercial-scale work on amorphous solid dispersions, particle engineering and finished dose manufacturing for pharma, consumer health
BioNTech’s African mRNA vaccine production push gets EU funding boost
As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company’s efforts.